Renzenbrink & Partner advised IK Investment Partners (Mid Cap VIII funds) on the acquisition of the LAP Group from capiton

18 June 2019

Renzenbrink & Partner advised funds advised by IK Investment Partners (Mid Cap VIII) on the acquisition of the LAP Group from capiton. Completion of the transaction is subject to approval by the antitrust authorities.

LAP GmbH Laser Applikationen was founded in 1984 and has developed into a leading supplier of laser projection systems for true-to-scale alignment and positioning within the health care and industrial segments. Headquartered in Lüneburg, Germany, the company has 350 employees and operates from 8 locations in Europe, America and Asia. At the beginning of the year, LAP acquired LifeLine, the global leader for radiation therapy QA software.

The aim of the transaction is to jointly expand the strong market position and the promising QA software offering and to open up new areas of application. LAP is the third mid-cap acquisition of the IK VIII fund this year.

Renzenbrink & Partner advised IK Investment Partners on all legal aspects of the transaction and tax structuring. The team consisted of the partners Dr Ulf Renzenbrink, Dr Andreas Stoll, Dr Dennis Schlottmann (all Corporate/M&A), Marc H. Kotyrba (Tax), Dr Gunnar L. Schmüser (Finance) as well as the associates Dr Niels Maier, Pablo Albrecht (both Corporate/M&A) and Dr Florian Seitz (Tax).

The debt financing was advised by Jan Wilms, Willkie Farr & Gallagher LLP.

The notarization was carried out by Dr Thomas Diehn, Notariat Bergstraße, Hamburg.